Evidence map›Paper›PMID 37887953›Full record

ReviewNanomaterials (Basel, Switzerland)2023

The Impressive Anti-Inflammatory Activity of Cerium Oxide Nanoparticles: More than Redox?

Francesca Corsi, Greta Deidda Tarquini, Marta Urbani, Ignacio Bejarano, Enrico Traversa, Lina Ghibelli

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. A Neutrophil Membrane-Encapsulated Pd/hCeOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Immunomodulatory Nanozymes as Programmable Redox-Immune Set-Point Regulators.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. The Protective Effect of N, Ce-doped Carbon Dots Against HApplied biochemistry and biotechnology · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Cu-CeOFrontiers in bioengineering and biotechnology · 2026
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Francesca CorsiDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-9334-4587
Greta Deidda TarquiniDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", 00133 Rome, Italy.
Marta UrbaniDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", 00133 Rome, Italy.
Ignacio BejaranoInstitute of Biomedicine of Seville (IBiS), University of Seville, HUVR, Junta de Andalucía, CSIC, 41013 Seville, Spain.ORCID 0000-0003-3727-3873
Enrico TraversaDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0001-6336-941X
Lina GhibelliDepartment of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
University of Rome Tor Vergata · ITInstituto de Biomedicina de Sevilla · ES

Funding

Regione Lazio A0375-2020-36660University of Rome Tor Vergata CRAC3D, Beyond Borders 2019
6 · The paper itself

Abstract

Cerium oxide nanoparticles (CNPs) are biocompatible nanozymes exerting multifunctional biomimetic activities, including superoxide dismutase (SOD), catalase, glutathione peroxidase, photolyase, and phosphatase. SOD- and catalase-mimesis depend on Ce

Indexed as

catalasecerium oxide nanoparticlesinflammationreactive oxygen speciesregenerationsuperoxide-dismutasetissue engineering

Identifiers

PMID37887953
PMCPMC10609664
OpenAlexW4387843353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.